טוען...
Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments
Since the discovery of camelid heavy-chain antibodies in 1993, there has been tremendous excitement for these antibody domains (VHHs/sdAbs/nanobodies) as research tools, diagnostics, and therapeutics. Commercially, several patents were granted to pioneering research groups in Belgium and the Netherl...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2022-04-01
|
| סדרה: | International Journal of Molecular Sciences |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/1422-0067/23/9/5009 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|